These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2204483)

  • 1. Ganglioside reduction of ischemic injury.
    Karpiak SE; Mahadik SP; Wakade CG
    Crit Rev Neurobiol; 1990; 5(3):221-37. PubMed ID: 2204483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of cerebral edema with GM1 ganglioside.
    Karpiak SE; Mahadik SP
    J Neurosci Res; 1984; 12(2-3):485-92. PubMed ID: 6094838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosialoganglioside effects following cerebral ischemia: relationship with anti-neuronotoxic and pro-neuronotrophic effects.
    Lipartiti M; Seren MS; Lazzaro A; Koga T; Mazzari S; Facci L; Fusco M; Toffano G; Leon A
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):489-94. PubMed ID: 2130663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monosialoganglioside GM1 reduces ischemia--reperfusion-induced injury in the rat retina.
    Weber M; Mohand-Said S; Hicks D; Dreyfus H; Sahel JA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):267-73. PubMed ID: 8603830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a unified theory of ganglioside-mediated functional restoration after brain injury: lesion size, not lesion site, is the primary factor determining efficacy.
    Ramirez JJ; Sabel BA
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):415-38. PubMed ID: 2130659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monosialoganglioside GM1 in cerebral ischemia.
    Carolei A; Fieschi C; Bruno R; Toffano G
    Cerebrovasc Brain Metab Rev; 1991; 3(2):134-57. PubMed ID: 1854596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
    Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ganglioside treatments on lesion-induced behavioral impairments and sprouting in the CNS.
    Fass B; Ramirez JJ
    J Neurosci Res; 1984; 12(2-3):445-58. PubMed ID: 6502760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside treatment: reduction of CNS injury and facilitation of functional recovery.
    Karpiak SE; Li YS; Mahadik SP
    Brain Inj; 1987; 1(2):161-70. PubMed ID: 2457399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats.
    Inokuchi J; Kuroda Y; Kosaka S; Fujiwara M
    Acta Biochim Pol; 1998; 45(2):479-92. PubMed ID: 9821877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain damage due to cerebral hypoxia/ischemia in the neonate: pathology and pharmacological modification.
    Tuor UI; Del Bigio MR; Chumas PD
    Cerebrovasc Brain Metab Rev; 1996; 8(2):159-93. PubMed ID: 8727185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function.
    Karpiak SE; Li YS; Mahadik SP
    Stroke; 1987; 18(1):184-7. PubMed ID: 3027926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of aging on recovery following ischemic brain damage.
    Yager JY; Wright S; Armstrong EA; Jahraus CM; Saucier DM
    Behav Brain Res; 2006 Oct; 173(2):171-80. PubMed ID: 16899307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gangliosides' dual mode of action: a working hypothesis.
    Janigro D; Di Gregorio F; Vyskocil F; Gorio A
    J Neurosci Res; 1984; 12(2-3):499-509. PubMed ID: 6094839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroprotection in cerebral ischemia].
    Martínez-Vila E; Vázquez Espiérrez C
    Neurologia; 1995 Dec; 10 Suppl 2():30-6. PubMed ID: 8714448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia.
    Yu YP; Xu QQ; Zhang Q; Zhang WP; Zhang LH; Wei EQ
    Neurosci Lett; 2005 Oct; 387(1):5-10. PubMed ID: 16054296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing recovery from ischemic stroke.
    Geldmacher DS
    Neurosurg Clin N Am; 1997 Apr; 8(2):245-51. PubMed ID: 9113706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethanol on neuroblastoma cells in culture: role of gangliosides in neuritogenesis and substrate adhesion.
    Leskawa KC; Maddox T; Webster KA
    J Neurosci Res; 1995 Oct; 42(3):377-84. PubMed ID: 8583506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of gangliosides: anatomical considerations.
    Emerich DF
    J Neural Transplant Plast; 1992; 3(1):1-19. PubMed ID: 1571395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.